Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of ResMed Inc.. A complete text table follows the diagram.
Masks, accessories and residential-care software add a $696M replenishment-and-SaaS layer around the sleep-therapy installed base
Swipe to explore
The filing does not label masks and software as recurring revenue. The visualization uses 'replenishment-and-SaaS layer' as an editorial description of replaceable masks/accessories and contracted software access, not as a reported recurring-revenue metric.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| ResMed revenue | 1 | $1.4B | Sleep therapy plus care software |
| Therapy devices | 2 | $736M | 51% of revenue |
| Masks and other | 2 | $525M | 37% of revenue; up 15% |
| Residential Care Software | 2 | $171M | SaaS for out-of-hospital care |
| U.S., Canada and Latin America | 3 | $819M | Device and mask revenue |
| Europe, Asia and other markets | 3 | $442M | Device and mask revenue |
| From | To | Value |
|---|---|---|
| ResMed revenue | Therapy devices | $736M |
| ResMed revenue | Masks and other | $525M |
| ResMed revenue | Residential Care Software | $171M |
| Therapy devices | U.S., Canada and Latin America | $448M |
| Therapy devices | Europe, Asia and other markets | $288M |
| Masks and other | U.S., Canada and Latin America | $371M |
| Masks and other | Europe, Asia and other markets | $154M |